Coronary Atherosclerotic Heart Disease
Conditions
Interventions
Observation group:None
Sponsors
The Second Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Availability of complete clinical baseline data (e.g., demographic information such as age and sex, blood pressure, blood lipid profile, and other laboratory test results); 2.Availability of complete cardiovascular health behavior assessment data (e.g., smoking, physical activity, diet, sleep, and psychological status); 3.Availability of complete optical coherence tomography (OCT) imaging data; 4.Age =18 years, including males or non-pregnant, non-lactating females; 5.At least one clinical follow-up of =6 months completed, with voluntary signed informed consent;
Exclusion criteria
Exclusion criteria: 1.Presence of severe comorbid systemic diseases, such as advanced malignancies, severe hepatic or renal failure, severe pulmonary diseases (e.g., end-stage chronic obstructive pulmonary disease, respiratory failure), or active autoimmune diseases; 2.Missing key variables (e.g., blood lipid profile, follow-up outcomes); 3.OCT images with artifacts that interfere with plaque characterization;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thin-cap fibrous atheroma; | — |
Secondary
| Measure | Time frame |
|---|---|
| Calcified plaque;Plaque rupture;Lipid-rich atherosclerotic plaque; | — |
Countries
China
Contacts
Public ContactXueqin Gao
The Second Affiliated Hospital of Harbin Medical University
Outcome results
None listed